Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 3 | 2024 | 1216 | 0.470 |
Why?
|
| Workplace | 2 | 2024 | 83 | 0.370 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2024 | 493 | 0.370 |
Why?
|
| Nitroglycerin | 1 | 2011 | 23 | 0.350 |
Why?
|
| Corneal Stroma | 2 | 2010 | 76 | 0.330 |
Why?
|
| Leg | 1 | 2011 | 121 | 0.330 |
Why?
|
| Qualitative Research | 3 | 2024 | 699 | 0.330 |
Why?
|
| Eye Injuries | 2 | 2010 | 49 | 0.330 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 108 | 0.330 |
Why?
|
| Heparin | 1 | 2011 | 204 | 0.320 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 199 | 0.320 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 193 | 0.310 |
Why?
|
| Epithelium, Corneal | 2 | 2010 | 175 | 0.310 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2010 | 215 | 0.300 |
Why?
|
| Neutrophils | 2 | 2010 | 361 | 0.300 |
Why?
|
| Ischemia | 1 | 2011 | 358 | 0.280 |
Why?
|
| CD18 Antigens | 1 | 2007 | 42 | 0.270 |
Why?
|
| Wound Healing | 2 | 2010 | 482 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2024 | 1055 | 0.190 |
Why?
|
| Faculty, Medical | 1 | 2024 | 279 | 0.170 |
Why?
|
| Learning | 2 | 2024 | 370 | 0.170 |
Why?
|
| Grounded Theory | 1 | 2020 | 7 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 551 | 0.120 |
Why?
|
| Head Injuries, Closed | 1 | 2014 | 46 | 0.100 |
Why?
|
| Vibrio vulnificus | 1 | 2013 | 4 | 0.100 |
Why?
|
| Orbital Fractures | 1 | 2014 | 39 | 0.100 |
Why?
|
| Vibrio Infections | 1 | 2013 | 14 | 0.100 |
Why?
|
| Orbit | 1 | 2014 | 81 | 0.100 |
Why?
|
| Spinal Puncture | 1 | 2013 | 52 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2024 | 444 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 173 | 0.090 |
Why?
|
| Toes | 1 | 2011 | 28 | 0.090 |
Why?
|
| Administration, Cutaneous | 1 | 2011 | 66 | 0.090 |
Why?
|
| Catheterization, Peripheral | 1 | 2013 | 126 | 0.090 |
Why?
|
| Femoral Artery | 1 | 2011 | 135 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 122 | 0.080 |
Why?
|
| Catheterization | 1 | 2011 | 226 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 546 | 0.080 |
Why?
|
| Hepatitis C | 1 | 2013 | 390 | 0.070 |
Why?
|
| Infant, Premature, Diseases | 1 | 2011 | 254 | 0.070 |
Why?
|
| Sepsis | 1 | 2013 | 497 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 1170 | 0.070 |
Why?
|
| Cell Migration Assays, Leukocyte | 1 | 2007 | 1 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2007 | 63 | 0.070 |
Why?
|
| Thrombosis | 1 | 2011 | 498 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 4017 | 0.060 |
Why?
|
| Collagen | 1 | 2007 | 278 | 0.060 |
Why?
|
| Infant, Premature | 1 | 2011 | 853 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 5199 | 0.060 |
Why?
|
| Child | 3 | 2022 | 26218 | 0.060 |
Why?
|
| Thailand | 1 | 2024 | 47 | 0.050 |
Why?
|
| Humans | 8 | 2024 | 130870 | 0.050 |
Why?
|
| Focus Groups | 1 | 2024 | 232 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2007 | 860 | 0.050 |
Why?
|
| Teaching | 1 | 2024 | 198 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 3040 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 4716 | 0.040 |
Why?
|
| Infant | 2 | 2013 | 13299 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8509 | 0.040 |
Why?
|
| Male | 5 | 2024 | 64772 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 4683 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12914 | 0.030 |
Why?
|
| Pediatrics | 1 | 2024 | 1247 | 0.030 |
Why?
|
| Mice | 2 | 2010 | 18268 | 0.030 |
Why?
|
| Exophthalmos | 1 | 2014 | 31 | 0.030 |
Why?
|
| Carotid Artery, Internal | 1 | 2014 | 56 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 5095 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 362 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 754 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2013 | 259 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2010 | 97 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 33982 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 225 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1892 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 872 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 31245 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3827 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4482 | 0.010 |
Why?
|
| Female | 1 | 2024 | 70560 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 15018 | 0.010 |
Why?
|